{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,14]],"date-time":"2026-03-14T04:56:03Z","timestamp":1773464163755,"version":"3.50.1"},"reference-count":124,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic Chemistry"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1016\/j.bioorg.2024.107983","type":"journal-article","created":{"date-parts":[[2024,11,22]],"date-time":"2024-11-22T15:27:51Z","timestamp":1732289271000},"page":"107983","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Clinical applications of small-molecule GABAAR modulators for neurological disorders"],"prefix":"10.1016","volume":"153","author":[{"given":"Guangyong","family":"Chen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Meiling","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhuo","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fuwei","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bioorg.2024.107983_b0005","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.neuropharm.2008.07.045","article-title":"GABA A receptors: subtypes provide diversity of function and pharmacology","volume":"56","author":"Olsen","year":"2009","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.bioorg.2024.107983_b0010","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1038\/nrn2372","article-title":"General anaesthesia: from molecular targets to neuronal pathways of sleep and arousal","volume":"9","author":"Franks","year":"2008","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.bioorg.2024.107983_b0015","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1038\/nrd3502","article-title":"Beyond classical benzodiazepines: novel therapeutic potential of GABAA receptor subtypes","volume":"10","author":"Rudolph","year":"2011","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.bioorg.2024.107983_b0020","doi-asserted-by":"crossref","DOI":"10.1016\/j.pbb.2021.173321","article-title":"The imidazodiazepine, KRM-II-81: An example of a newly emerging generation of GABAkines for neurological and psychiatric disorders","volume":"213","author":"Witkin","year":"2022","journal-title":"Pharmacol. Biochem. Behav"},{"key":"10.1016\/j.bioorg.2024.107983_b0025","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1016\/j.tips.2018.03.006","article-title":"The Benzodiazepine Binding Sites of GABA(A) Receptors","volume":"39","author":"Sigel","year":"2018","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.bioorg.2024.107983_b0030","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1016\/j.neuropharm.2010.10.020","article-title":"The rise of a new GABA pharmacology","volume":"60","author":"M\u00f6hler","year":"2011","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.bioorg.2024.107983_b0035","doi-asserted-by":"crossref","first-page":"2086","DOI":"10.1111\/j.1360-0443.2011.03563.x","article-title":"Benzodiazepines revisited\u2013will we ever learn?","volume":"106","author":"Lader","year":"2011","journal-title":"Addiction"},{"key":"10.1016\/j.bioorg.2024.107983_b0040","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1586\/17512433.2014.864949","article-title":"Non-benzodiazepine hypnotics and older adults: what are we learning about zolpidem?","volume":"7","author":"Levy","year":"2014","journal-title":"Expert. Rev. Clin. Pharmacol."},{"key":"10.1016\/j.bioorg.2024.107983_b0045","first-page":"22","article-title":"Zolpidem (ivadal) treatment of sleep disorders","volume":"101","author":"Aleksandrovski\u012d Iu","year":"2001","journal-title":"Zh. Nevrol. Psikhiatr. Im. S S Korsakova"},{"key":"10.1016\/j.bioorg.2024.107983_b0050","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1111\/j.1528-1167.2010.02870.x","article-title":"Neurosteroids as endogenous regulators of seizure susceptibility and use in the treatment of epilepsy","volume":"51","author":"Reddy","year":"2010","journal-title":"Epilepsia"},{"key":"10.1016\/j.bioorg.2024.107983_b0055","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1038\/nrn1703","article-title":"Neurosteroids: endogenous regulators of the GABA(A) receptor","volume":"6","author":"Belelli","year":"2005","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.bioorg.2024.107983_b0060","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1016\/S0140-6736(17)31264-3","article-title":"Brexanolone (SAGE-547 injection) in post-partum depression: a randomised controlled trial","volume":"390","author":"Kanes","year":"2017","journal-title":"Lancet"},{"key":"10.1016\/j.bioorg.2024.107983_b0065","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1186\/s43141-021-00224-0","article-title":"GABA(A) receptors: structure, function, pharmacology, and related disorders","volume":"19","author":"Ghit","year":"2021","journal-title":"J. Genet. Eng. Biotechnol."},{"key":"10.1016\/j.bioorg.2024.107983_b0070","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1007\/s40263-023-01027-2","article-title":"New GABA-Targeting Therapies for the Treatment of Seizures and Epilepsy: I. Role of GABA as a Modulator of Seizure Activity and Recently Approved Medications Acting on the GABA System","volume":"37","author":"Perucca","year":"2023","journal-title":"CNS Drugs"},{"key":"10.1016\/j.bioorg.2024.107983_b0075","article-title":"Eszopiclone for insomnia","volume":"10","author":"R\u00f6sner","year":"2018","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.bioorg.2024.107983_b0080","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1126\/science.aax5719","article-title":"Shisa7 is a GABA(A) receptor auxiliary subunit controlling benzodiazepine actions","volume":"366","author":"Han","year":"2019","journal-title":"Science"},{"key":"10.1016\/j.bioorg.2024.107983_b0085","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.cell.2024.09.006","article-title":"The TMEM132B-GABA(A) receptor complex controls alcohol actions in the brain","volume":"187","author":"Wang","year":"2024","journal-title":"Cell"},{"key":"10.1016\/j.bioorg.2024.107983_b0090","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1016\/j.tips.2018.04.003","article-title":"An Emerging Circuit Pharmacology of GABA(A) Receptors","volume":"39","author":"Engin","year":"2018","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.bioorg.2024.107983_b0095","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1016\/j.tins.2013.08.006","article-title":"Modulation of neuronal activity by phosphorylation of the K-Cl cotransporter KCC2","volume":"36","author":"Kahle","year":"2013","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.bioorg.2024.107983_b0100","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1038\/s41586-022-04517-3","article-title":"Differential assembly diversifies GABA(A) receptor structures and signalling","volume":"604","author":"Sente","year":"2022","journal-title":"Nature"},{"key":"10.1016\/j.bioorg.2024.107983_b0105","doi-asserted-by":"crossref","first-page":"1784","DOI":"10.3390\/biom12121784","article-title":"Benzodiazepine Modulation of GABA(A) Receptors: A Mechanistic Perspective","volume":"12","author":"Goldschen-Ohm","year":"2022","journal-title":"Biomolecules"},{"issue":"Suppl 3","key":"10.1016\/j.bioorg.2024.107983_b0110","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1046\/j.1528-1157.2001.042suppl.3008.x","article-title":"GABAergic mechanisms in epilepsy","volume":"42","author":"Treiman","year":"2001","journal-title":"Epilepsia"},{"key":"10.1016\/j.bioorg.2024.107983_b0115","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1038\/nrn1430","article-title":"The neurobiology of antiepileptic drugs","volume":"5","author":"Rogawski","year":"2004","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.bioorg.2024.107983_b0120","unstructured":"R.L. Macdonald, J.Q. Kang, M.J. Gallagher, GABA(A) Receptor Subunit Mutations and Genetic Epilepsies, in: J.L. Noebels, M. Avoli, M.A. Rogawski, R.W. Olsen, A.V. Delgado-Escueta (Eds.) Jasper's Basic Mechanisms of the Epilepsies, National Center for Biotechnology Information (US). Copyright \u00a9 2012, Michael A Rogawski, Antonio V Delgado-Escueta, Jeffrey L Noebels, Massimo Avoli and Richard W Olsen., Bethesda (MD), 2012."},{"key":"10.1016\/j.bioorg.2024.107983_b0125","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1192\/bjp.179.5.390","article-title":"New insights into the role of the GABA(A)-benzodiazepine receptor in psychiatric disorder","volume":"179","author":"Nutt","year":"2001","journal-title":"Br. J. Psychiatry"},{"key":"10.1016\/j.bioorg.2024.107983_b0130","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1146\/annurev.pharmtox.44.101802.121429","article-title":"Analysis of GABAA receptor function and dissection of the pharmacology of benzodiazepines and general anesthetics through mouse genetics","volume":"44","author":"Rudolph","year":"2004","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"10.1016\/j.bioorg.2024.107983_b0135","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.coph.2005.10.004","article-title":"Gaboxadol\u2013a new awakening in sleep","volume":"6","author":"Wafford","year":"2006","journal-title":"Curr. Opin. Pharmacol."},{"key":"10.1016\/j.bioorg.2024.107983_b0140","first-page":"149","article-title":"Sleep-wake rhythm disorders in the framework of a Diogenes syndrome. Improvement in Sleep Architecture Using Supportive Treatment with Zolpidem","volume":"113","author":"Kummer","year":"1995","journal-title":"Fortschr Med"},{"key":"10.1016\/j.bioorg.2024.107983_b0145","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.conb.2013.11.003","article-title":"Inhibitory neurons in human cortical circuits: substrate for cognitive dysfunction in schizophrenia","volume":"26","author":"Lewis","year":"2014","journal-title":"Curr. Opin. Neurobiol."},{"key":"10.1016\/j.bioorg.2024.107983_b0150","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0893-133X(01)00225-1","article-title":"GABAergic interneurons: implications for understanding schizophrenia and bipolar disorder","volume":"25","author":"Benes","year":"2001","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.bioorg.2024.107983_b0155","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.brainresrev.2006.04.001","article-title":"Molecular and cellular mechanisms of altered GAD1\/GAD67 expression in schizophrenia and related disorders","volume":"52","author":"Akbarian","year":"2006","journal-title":"Brain Res. Rev."},{"key":"10.1016\/j.bioorg.2024.107983_b0160","doi-asserted-by":"crossref","unstructured":"P. Brambilla, J. Perez, F. Barale, G. Schettini, J.C. Soares, GABAergic dysfunction in mood disorders, Mol Psychiatry, 8 (2003) 721-737, 715.","DOI":"10.1038\/sj.mp.4001362"},{"key":"10.1016\/j.bioorg.2024.107983_b0165","doi-asserted-by":"crossref","first-page":"e303","DOI":"10.1038\/tp.2013.64","article-title":"Expression of GABAA \u03b12-, \u03b21- and \u03b5-receptors are altered significantly in the lateral cerebellum of subjects with schizophrenia, major depression and bipolar disorder","volume":"3","author":"Fatemi","year":"2013","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/j.bioorg.2024.107983_b0170","doi-asserted-by":"crossref","DOI":"10.1016\/j.conctc.2023.101122","article-title":"Lorazepam use during clinical trials of adults with bipolar mania episodes","volume":"33","author":"Safer","year":"2023","journal-title":"Contemp. Clin. Trials Commun."},{"key":"10.1016\/j.bioorg.2024.107983_b0175","doi-asserted-by":"crossref","first-page":"70","DOI":"10.3389\/fped.2014.00070","article-title":"GABAergic signaling as therapeutic target for autism spectrum disorders","volume":"2","author":"Cellot","year":"2014","journal-title":"Front. Pediatr."},{"key":"10.1016\/j.bioorg.2024.107983_b0180","doi-asserted-by":"crossref","first-page":"2044","DOI":"10.1016\/j.neubiorev.2012.07.005","article-title":"GABA system dysfunction in autism and related disorders: from synapse to symptoms","volume":"36","author":"Coghlan","year":"2012","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.bioorg.2024.107983_b0185","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.rasd.2011.06.007","article-title":"Tactile responsiveness patrerns and their association with core features in autism spectrum disorders","volume":"6","author":"Foss-Feig","year":"2012","journal-title":"Res. Autism Spectr. Disord."},{"key":"10.1016\/j.bioorg.2024.107983_b0190","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1016\/j.cell.2019.12.036","article-title":"Large-Scale Exome Sequencing Study Implicates Both Developmental and Functional Changes in the Neurobiology of Autism","volume":"180","author":"Satterstrom","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.bioorg.2024.107983_b0195","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2024.109897","article-title":"Novel pharmacological targets for GABAergic dysfunction in ADHD","volume":"249","author":"Ferranti","year":"2024","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.bioorg.2024.107983_b0200","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.eurpsy.2009.06.001","article-title":"Possible association between attention deficit hyperactivity disorder and attempted suicide in adolescents - a pilot study","volume":"25","author":"Manor","year":"2010","journal-title":"Eur. Psychiatry"},{"key":"10.1016\/j.bioorg.2024.107983_b0205","doi-asserted-by":"crossref","first-page":"e999","DOI":"10.1038\/tp.2016.273","article-title":"Glutamatergic and GABAergic gene sets in attention-deficit\/hyperactivity disorder: association to overlapping traits in ADHD and autism","volume":"7","author":"Naaijen","year":"2017","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/j.bioorg.2024.107983_b0210","doi-asserted-by":"crossref","DOI":"10.3389\/fncir.2023.1218737","article-title":"GABAergic signaling in alcohol use disorder and withdrawal: pathological involvement and therapeutic potential","volume":"17","author":"Dharavath","year":"2023","journal-title":"Front. Neural Circuits"},{"key":"10.1016\/j.bioorg.2024.107983_b0215","doi-asserted-by":"crossref","DOI":"10.1016\/j.nbd.2022.105610","article-title":"Alcohol dependence and withdrawal increase sensitivity of central amygdalar GABAergic synapses to the glucocorticoid receptor antagonist mifepristone in male rats","volume":"164","author":"Khom","year":"2022","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.bioorg.2024.107983_b0220","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1038\/aps.2014.50","article-title":"Alcohol use disorders and current pharmacological therapies: the role of GABA(A) receptors","volume":"35","author":"Liang","year":"2014","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.bioorg.2024.107983_b0225","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1196\/annals.1300.010","article-title":"NMDA receptor antagonism and the ethanol intoxication signal: from alcoholism risk to pharmacotherapy","volume":"1003","author":"Krystal","year":"2003","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.bioorg.2024.107983_b0230","first-page":"589","article-title":"Outpatient management of alcohol withdrawal syndrome","volume":"88","author":"Muncie","year":"2013","journal-title":"Am. Fam. Physician"},{"issue":"Suppl 1","key":"10.1016\/j.bioorg.2024.107983_b0235","first-page":"11","article-title":"Structural and functional brain changes in posttraumatic stress disorder","volume":"65","author":"Nutt","year":"2004","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.bioorg.2024.107983_b0240","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1001\/archpsyc.1990.01810220033004","article-title":"Flumazenil provocation of panic attacks. Evidence for Altered Benzodiazepine Receptor Sensitivity in Panic Disorder","volume":"47","author":"Nutt","year":"1990","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.bioorg.2024.107983_b0245","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1177\/10600280231204953","article-title":"Zuranolone: The First FDA-Approved Oral Treatment Option for Postpartum Depression","volume":"58","author":"Barnes","year":"2024","journal-title":"Ann. Pharmacother."},{"key":"10.1016\/j.bioorg.2024.107983_b0250","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/j.clinthera.2024.04.001","article-title":"Zuranolone: A Narrative Review of a New Oral Treatment for Postpartum Depression","volume":"46","author":"Hitt","year":"2024","journal-title":"Clin. Ther."},{"key":"10.1016\/j.bioorg.2024.107983_b0255","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1001\/jamapsychiatry.2021.1559","article-title":"Effect of Zuranolone vs Placebo in Postpartum Depression: A Randomized Clinical Trial","volume":"78","author":"Deligiannidis","year":"2021","journal-title":"JAMA Psychiat."},{"key":"10.1016\/j.bioorg.2024.107983_b0260","doi-asserted-by":"crossref","unstructured":"G. Martinez Botella, F.G. Salituro, B.L. Harrison, R.T. Beresis, Z. Bai, M.J. Blanco, G.M. Belfort, J. Dai, C.M. Loya, M.A. Ackley, A.L. Althaus, S.J. Grossman, E. Hoffmann, J.J. Doherty, A.J. Robichaud, Neuroactive Steroids. 2. 3\u03b1-Hydroxy-3\u03b2-methyl-21-(4-cyano-1H-pyrazol-1'-yl)-19-nor-5\u03b2-pregnan-20-one (SAGE-217): A Clinical Next Generation Neuroactive Steroid Positive Allosteric Modulator of the (\u03b3-Aminobutyric Acid)(A) Receptor, J Med Chem, 60 (2017) 7810-7819.","DOI":"10.1021\/acs.jmedchem.7b00846"},{"key":"10.1016\/j.bioorg.2024.107983_b0265","doi-asserted-by":"crossref","first-page":"1576","DOI":"10.1093\/brain\/awab042","article-title":"Medial septal GABAergic neurons reduce seizure duration upon optogenetic closed-loop stimulation","volume":"144","author":"Hristova","year":"2021","journal-title":"Brain"},{"key":"10.1016\/j.bioorg.2024.107983_b0270","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1016\/S0022-3565(24)36511-5","article-title":"Characterization of the anticonvulsant properties of ganaxolone (CCD 1042; 3alpha-hydroxy-3beta-methyl-5alpha-pregnan-20-one), a selective, high-affinity, steroid modulator of the gamma-aminobutyric acid(A) receptor","volume":"280","author":"Carter","year":"1997","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.bioorg.2024.107983_b0275","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/S1474-4422(22)00077-1","article-title":"Safety and efficacy of ganaxolone in patients with CDKL5 deficiency disorder: results from the double-blind phase of a randomised, placebo-controlled, phase 3 trial","volume":"21","author":"Knight","year":"2022","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.bioorg.2024.107983_b0280","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1021\/jm960021x","article-title":"Synthesis and in vitro activity of 3 beta-substituted-3 alpha-hydroxypregnan-20-ones: allosteric modulators of the GABAA receptor","volume":"40","author":"Hogenkamp","year":"1997","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2024.107983_b0285","doi-asserted-by":"crossref","first-page":"495","DOI":"10.14740\/jmc4013","article-title":"Remimazolam for Sedation During Upper Gastrointestinal Endoscopy in an Adolescent","volume":"13","author":"Garrett","year":"2022","journal-title":"J Med Cases"},{"key":"10.1016\/j.bioorg.2024.107983_b0290","first-page":"274","article-title":"A placebo- and midazolam-controlled phase I single ascending-dose study evaluating the safety, pharmacokinetics, and pharmacodynamics of remimazolam (CNS 7056): Part I","volume":"115","author":"Antonik","year":"2012","journal-title":"Safety, Efficacy, and Basic Pharmacokinetics, Anesth Analg"},{"key":"10.1016\/j.bioorg.2024.107983_b0295","doi-asserted-by":"crossref","first-page":"413","DOI":"10.2147\/DDDT.S344240","article-title":"Protective Effects of Remimazolam on Cerebral Ischemia\/Reperfusion Injury in Rats by Inhibiting of NLRP3 Inflammasome-Dependent Pyroptosis","volume":"16","author":"Shi","year":"2022","journal-title":"Drug Des. Devel. Ther."},{"key":"10.1016\/j.bioorg.2024.107983_b0300","doi-asserted-by":"crossref","first-page":"3957","DOI":"10.2147\/DDDT.S384155","article-title":"Remimazolam: An Updated Review of a New Sedative and Anaesthetic","volume":"16","author":"Hu","year":"2022","journal-title":"Drug Des. Devel. Ther."},{"key":"10.1016\/j.bioorg.2024.107983_b0305","article-title":"Preparation of short-acting benzodiazepines","author":"Feldman","year":"2000","journal-title":"Glaxo Group Limited"},{"key":"10.1016\/j.bioorg.2024.107983_b0310","unstructured":"S.G. Tilbrook, A. Schumacher, R. Emmenegger, Process for preparation of benzodiazepine derivative, 2011, WO2011032692A1."},{"key":"10.1016\/j.bioorg.2024.107983_b0315","first-page":"500","article-title":"Update on Antiseizure Medications 2022","volume":"28","author":"Abou-Khalil","year":"2022","journal-title":"Continuum (minneap Minn)"},{"key":"10.1016\/j.bioorg.2024.107983_b0320","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2022.109292","article-title":"Cognitive and behavioral effects of the anti-epileptic drug cenobamate (YKP3089) and underlying synaptic and cellular mechanisms","volume":"221","author":"Song","year":"2022","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.bioorg.2024.107983_b0325","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/S1474-4422(19)30399-0","article-title":"Safety and efficacy of adjunctive cenobamate (YKP3089) in patients with uncontrolled focal seizures: a multicentre, double-blind, randomised, placebo-controlled, dose-response trial","volume":"19","author":"Krauss","year":"2020","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.bioorg.2024.107983_b0330","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2023.e18920","article-title":"Anticonvulsant effects of cenobamate in chemically and electrically induced seizure models in rodents","volume":"9","author":"Melnick","year":"2023","journal-title":"Heliyon"},{"key":"10.1016\/j.bioorg.2024.107983_b0335","article-title":"Preparation of triazoles and tetrazoles containing carbamoyl group as anticonvulsants","author":"Choi","year":"2006","journal-title":"SK Corporation"},{"key":"10.1016\/j.bioorg.2024.107983_b0340","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1177\/1060028019873320","article-title":"Brexanolone (Zulresso): Finally, an FDA-Approved Treatment for Postpartum Depression","volume":"54","author":"Powell","year":"2020","journal-title":"Ann. Pharmacother."},{"key":"10.1016\/j.bioorg.2024.107983_b0345","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.neuron.2008.06.019","article-title":"GABA(A)R plasticity during pregnancy: relevance to postpartum depression","volume":"59","author":"Maguire","year":"2008","journal-title":"Neuron"},{"key":"10.1016\/j.bioorg.2024.107983_b0350","doi-asserted-by":"crossref","first-page":"6012","DOI":"10.1021\/jm900712n","article-title":"Development and screening of water-soluble analogues of progesterone and allopregnanolone in models of brain injury","volume":"52","author":"MacNevin","year":"2009","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2024.107983_b0355","first-page":"301","article-title":"New drug, fospropofol disodium: a propofol prodrug","volume":"77","author":"Welliver","year":"2009","journal-title":"AANA J."},{"key":"10.1016\/j.bioorg.2024.107983_b0360","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1097\/00003643-200303000-00002","article-title":"Pharmacokinetics and pharmacodynamics of the new propofol prodrug GPI 15715 in rats","volume":"20","author":"Schywalsky","year":"2003","journal-title":"Eur. J. Anaesthesiol."},{"key":"10.1016\/j.bioorg.2024.107983_b0365","article-title":"Efficacy and Safety of Fospropofol Disodium for Injection in General Anesthesia Induction for Adult Patients: A Phase 3 Trial","volume":"12","author":"Wu","year":"2021","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.bioorg.2024.107983_b0370","unstructured":"V.J. Stella, J.J. Zygmunt, I.G. Georg, M.S. Safadi, Water-soluble prodrugs of hindered alcohols or phenols, 2000, WO0008033A1."},{"key":"10.1016\/j.bioorg.2024.107983_b0375","doi-asserted-by":"crossref","DOI":"10.1177\/17562864231191000","article-title":"Pharmacological diversity amongst approved and emerging antiseizure medications for the treatment of developmental and epileptic encephalopathies","volume":"16","author":"Sills","year":"2023","journal-title":"Ther. Adv. Neurol. Disord."},{"key":"10.1016\/j.bioorg.2024.107983_b0380","doi-asserted-by":"crossref","first-page":"153","DOI":"10.2165\/00003495-199448020-00003","article-title":"New anticonvulsant drugs. Focus on Flunarizine, Fosphenytoin, Midazolam and Stiripentol","volume":"48","author":"Bebin","year":"1994","journal-title":"Drugs"},{"key":"10.1016\/j.bioorg.2024.107983_b0385","doi-asserted-by":"crossref","first-page":"2035","DOI":"10.1111\/epi.14563","article-title":"Recurrent epileptiform discharges in the medial entorhinal cortex of kainate-treated rats are differentially sensitive to antiseizure drugs","volume":"59","author":"West","year":"2018","journal-title":"Epilepsia"},{"key":"10.1016\/j.bioorg.2024.107983_b0390","article-title":"Preparation method of stiripentol","author":"Hu","year":"2012","journal-title":"Hunan University"},{"key":"10.1016\/j.bioorg.2024.107983_b0395","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1124\/jpet.108.146084","article-title":"The modulation of synaptic GABA(A) receptors in the thalamus by eszopiclone and zolpidem","volume":"328","author":"Jia","year":"2009","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.bioorg.2024.107983_b0400","doi-asserted-by":"crossref","DOI":"10.1093\/sleep\/zsx098","article-title":"Plasticity-Related Gene Expression During Eszopiclone-Induced Sleep","volume":"40","author":"Gerashchenko","year":"2017","journal-title":"Sleep"},{"key":"10.1016\/j.bioorg.2024.107983_b0405","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1093\/sleep\/26.7.793","article-title":"Sustained efficacy of eszopiclone over 6 months of nightly treatment: results of a randomized, double-blind, placebo-controlled study in adults with chronic insomnia","volume":"26","author":"Krystal","year":"2003","journal-title":"Sleep"},{"key":"10.1016\/j.bioorg.2024.107983_b0410","doi-asserted-by":"crossref","first-page":"41","DOI":"10.2146\/ajhp050357","article-title":"Eszopiclone","volume":"63","author":"Halas","year":"2006","journal-title":"Am. J. Health Syst. Pharm."},{"key":"10.1016\/j.bioorg.2024.107983_b0415","unstructured":"C. Wu, Process for chiral synthesis of eszopiclone, 2012, CN102675318A."},{"key":"10.1016\/j.bioorg.2024.107983_b0420","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1038\/clpt.1988.39","article-title":"Relation of sedation and amnesia to plasma concentrations of midazolam in surgical patients","volume":"43","author":"Persson","year":"1988","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.bioorg.2024.107983_b0425","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1097\/00000542-198503000-00017","article-title":"Midazolam: pharmacology and uses","volume":"62","author":"Reves","year":"1985","journal-title":"Anesthesiology"},{"key":"10.1016\/j.bioorg.2024.107983_b0430","doi-asserted-by":"crossref","unstructured":"A. Walser, L.E. Benjamin, T. Flynn, C. Mason, R. Schwartz, R.I. Fryer, Quinazolines and 1,4-benzodiazepines. 84. Synthesis and reactions of imidazo[1,5-a][1,4]benzodiazepines, J Org Chem, 43 (1978) 936-944.","DOI":"10.1021\/jo00399a029"},{"key":"10.1016\/j.bioorg.2024.107983_b0435","unstructured":"M.K. Dhaon, Thermal decarboxylation and crystallization process for the preparation of midazolam, 2001, WO2001070744A.."},{"key":"10.1016\/j.bioorg.2024.107983_b0440","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1517\/13543784.9.4.841","article-title":"Zaleplon - a review of a novel sedative hypnotic used in the treatment of insomnia","volume":"9","author":"Heydorn","year":"2000","journal-title":"Expert Opin. Invest. Drugs"},{"key":"10.1016\/j.bioorg.2024.107983_b0445","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1002\/1099-1166(200008)15:8<704::AID-GPS183>3.0.CO;2-S","article-title":"Zaleplon shortens subjective sleep latency and improves subjective sleep quality in elderly patients with insomnia. The Zaleplon Clinical Investigator Study Group","volume":"15","author":"Hedner","year":"2000","journal-title":"Int J Geriatr Psychiatry"},{"key":"10.1016\/j.bioorg.2024.107983_b0450","unstructured":"Q. Ma, Y. Zhang, Q. Yin, P. Sun, X. Zhu, B. Li, Zaleplon and its preparation method thereof, 2012, CN102584831A."},{"key":"10.1016\/j.bioorg.2024.107983_b0455","series-title":"Topiramate, StatPearls, StatPearls Publishing Copyright \u00a9 2024","author":"Fariba","year":"2024"},{"key":"10.1016\/j.bioorg.2024.107983_b0460","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1111\/head.12826","article-title":"Topiramate for Treatment in Patients With Migraine and Epilepsy","volume":"56","author":"Spritzer","year":"2016","journal-title":"Headache"},{"key":"10.1016\/j.bioorg.2024.107983_b0465","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1177\/106002809703101010","article-title":"Topiramate: a new antiepileptic drug","volume":"31","author":"Privitera","year":"1997","journal-title":"Ann. Pharmacother."},{"key":"10.1016\/j.bioorg.2024.107983_b0470","unstructured":"L.-H. Wang, C.-T. Huang, H. Chan, Process for the preparation and purification of topiramate, 2011, US20120232258A1."},{"key":"10.1016\/j.bioorg.2024.107983_b0475","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1097\/00000542-198908000-00015","article-title":"Propofol: a new intravenous anesthetic","volume":"71","author":"Sebel","year":"1989","journal-title":"Anesthesiology"},{"key":"10.1016\/j.bioorg.2024.107983_b0480","first-page":"1005","article-title":"Propofol","volume":"81","author":"Smith","year":"1994","journal-title":"An Update on Its Clinical Use, Anesthesiology"},{"key":"10.1016\/j.bioorg.2024.107983_b0485","unstructured":"A.K. Sharma, M. Pandey, A. Giri, S.S. Sokhi, G. Singh, S. Lahiri, W. Cabri, Process for the preparation of propofol, 2021, WO2021191832A1."},{"key":"10.1016\/j.bioorg.2024.107983_b0490","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/0149-7634(86)90026-6","article-title":"Is tofisopam an atypical anxiolytic?","volume":"10","author":"Pellow","year":"1986","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.bioorg.2024.107983_b0495","first-page":"309","article-title":"Tofizopam: a benzodiazepine derivative without sedative effect","volume":"20","author":"Kanto","year":"1982","journal-title":"Int. J. Clin. Pharmacol. Ther. Toxicol."},{"key":"10.1016\/j.bioorg.2024.107983_b0500","first-page":"79","article-title":"Pharmacologic effects of tofizopam","volume":"63","author":"Pet\u00f3cz","year":"1993","journal-title":"Acta Pharm. Hung."},{"key":"10.1016\/j.bioorg.2024.107983_b0505","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1176\/ajp.136.2.196","article-title":"Comparative efficacy of tofisopam and placebo","volume":"136","author":"Goldberg","year":"1979","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.bioorg.2024.107983_b0510","author":"Sun","year":"2018","journal-title":"Method for Synthesizing Tofisopam"},{"key":"10.1016\/j.bioorg.2024.107983_b0515","unstructured":"A. Jagtap, M. Gharpure, N. Shinde, N. Patil, C. Shah, C. Raut, D. Krishnmurthy, An improved process for the preparation of clobazam and its intermediate, 2016, WO2016151464A1."},{"key":"10.1016\/j.bioorg.2024.107983_b0520","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1126\/science.918669","article-title":"Benzodiazepine receptor: demonstration in the central nervous system","volume":"198","author":"M\u00f6hler","year":"1977","journal-title":"Science"},{"key":"10.1016\/j.bioorg.2024.107983_b0525","doi-asserted-by":"crossref","first-page":"9335","DOI":"10.1038\/s41598-021-88599-5","article-title":"Diazepam causes sedative rather than anxiolytic effects in C57BL\/6J mice","volume":"11","author":"P\u00e1dua-Reis","year":"2021","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bioorg.2024.107983_b0530","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1093\/bja\/51.5.439","article-title":"Comparison of the actions of diazepam and lorazepam","volume":"51","author":"Dundee","year":"1979","journal-title":"Br. J. Anaesth."},{"key":"10.1016\/j.bioorg.2024.107983_b0535","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1097\/00000542-196908000-00019","article-title":"The effects of diazepam","volume":"31","author":"Weaver","year":"1969","journal-title":"Anesthesiology"},{"key":"10.1016\/j.bioorg.2024.107983_b0540","unstructured":"X. Feng, L. Fu, J. Liao, G. Li, Y. Wang, Process for preparation of diazepam intermediate 5-chloro-1-methyl-3-phenyl-2,1-benzisoxazolium methylcarbonate, 2015, CN104356081A."},{"key":"10.1016\/j.bioorg.2024.107983_b0545","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.jpainsymman.2016.05.004","article-title":"Furosemide","volume":"52","author":"Carone","year":"2016","journal-title":"J. Pain Symptom Manage."},{"key":"10.1016\/j.bioorg.2024.107983_b0550","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1111\/j.1365-2710.1995.tb00620.x","article-title":"Effects of water deprivation for 48 hours on the pharmacokinetics and pharmacodynamics of furosemide in rats","volume":"20","author":"Kang","year":"1995","journal-title":"J. Clin. Pharm. Ther."},{"key":"10.1016\/j.bioorg.2024.107983_b0555","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1007\/s10741-020-10003-7","article-title":"Comparative effects of furosemide and other diuretics in the treatment of heart failure: a systematic review and combined meta-analysis of randomized controlled trials","volume":"26","author":"Eid","year":"2021","journal-title":"Heart Fail. Rev."},{"key":"10.1016\/j.bioorg.2024.107983_b0560","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1111\/j.1365-2044.2009.06228.x","article-title":"Benefits and risks of furosemide in acute kidney injury","volume":"65","author":"Ho","year":"2010","journal-title":"Anaesthesia"},{"key":"10.1016\/j.bioorg.2024.107983_b0565","author":"Tao","year":"2016","journal-title":"Method for Preparing Furosemide"},{"issue":"Suppl 2","key":"10.1016\/j.bioorg.2024.107983_b0570","first-page":"S2","article-title":"Antiepileptic drug mechanisms of action","volume":"36","author":"Macdonald","year":"1995","journal-title":"Epilepsia"},{"key":"10.1016\/j.bioorg.2024.107983_b0575","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1111\/j.1528-1157.1997.tb01728.x","article-title":"GABA and epileptogenesis","volume":"38","author":"Olsen","year":"1997","journal-title":"Epilepsia"},{"key":"10.1016\/j.bioorg.2024.107983_b0580","doi-asserted-by":"crossref","first-page":"3343","DOI":"10.1016\/j.clinph.2016.07.007","article-title":"Phenobarbital reduces EEG amplitude and propagation of neonatal seizures but does not alter performance of automated seizure detection","volume":"127","author":"Mathieson","year":"2016","journal-title":"Clin. Neurophysiol."},{"key":"10.1016\/j.bioorg.2024.107983_b0585","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1016\/S0040-4039(00)77752-5","article-title":"The \u03b1-arylation of derivatives of malonic acid with aryllead triacetates. New Syntheses of Ibuprofen and Phenobarbital","volume":"21","author":"Pinhey","year":"1980","journal-title":"Tetrahedron Lett."},{"key":"10.1016\/j.bioorg.2024.107983_b0590","doi-asserted-by":"crossref","first-page":"1865","DOI":"10.1007\/s00213-014-3457-x","article-title":"The behavioral pharmacology of zolpidem: evidence for the functional significance of \u03b11-containing GABA(A) receptors","volume":"231","author":"Fitzgerald","year":"2014","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.bioorg.2024.107983_b0595","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1023\/A:1006943009192","article-title":"Metabolism of anxiolytics and hypnotics: benzodiazepines, buspirone, zoplicone, and zolpidem","volume":"19","author":"Chouinard","year":"1999","journal-title":"Cell. Mol. Neurobiol."},{"key":"10.1016\/j.bioorg.2024.107983_b0600","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/S1389-9457(99)00006-4","article-title":"A five week, polysomnographic assessment of zaleplon 10 mg for the treatment of primary insomnia","volume":"1","author":"Walsh","year":"2000","journal-title":"Sleep Med."},{"key":"10.1016\/j.bioorg.2024.107983_b0605","unstructured":"B. Yang, G. Chen, X. Li, C. Sun, Preparation method of Zolpidem tartrate and its intermediate, 2017, CN106749237A."},{"key":"10.1016\/j.bioorg.2024.107983_b0610","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s002130050422","volume":"134","author":"Griffiths","year":"1997","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.bioorg.2024.107983_b0615","series-title":"Jasper's Basic Mechanisms of the Epilepsies, National Center for Biotechnology Information (US) Copyright \u00a9 2012, Michael A Rogawski, Antonio V Delgado-Escueta, Jeffrey L Noebels","article-title":"Neurosteroids \u2014 Endogenous Regulators of Seizure Susceptibility and Role in the Treatment of Epilepsy","author":"Reddy","year":"2012"},{"key":"10.1016\/j.bioorg.2024.107983_b0620","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1038\/12207","article-title":"Decreased GABAA-receptor clustering results in enhanced anxiety and a bias for threat cues","volume":"2","author":"Crestani","year":"1999","journal-title":"Nat. Neurosci."}],"container-title":["Bioorganic Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206824008885?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206824008885?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,30]],"date-time":"2025-01-30T02:30:32Z","timestamp":1738204232000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0045206824008885"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12]]},"references-count":124,"alternative-id":["S0045206824008885"],"URL":"https:\/\/doi.org\/10.1016\/j.bioorg.2024.107983","relation":{},"ISSN":["0045-2068"],"issn-type":[{"value":"0045-2068","type":"print"}],"subject":[],"published":{"date-parts":[[2024,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clinical applications of small-molecule GABAAR modulators for neurological disorders","name":"articletitle","label":"Article Title"},{"value":"Bioorganic Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bioorg.2024.107983","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"107983"}}